A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

A. M. Wilson; L. C. Orr; W. J. R. Coutie; E. J. Sims; B. J. Lipworth

doi:10.1046/j.0022-0477.2001.01252.x

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

A. M. Wilson, L. C. Orr, W. J. R. Coutie, E. J. Sims, B. J. Lipworth

Research output: Contribution to journal › Article › peer-review

57 Citations (Scopus)

Abstract

The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.

Original language	English
Pages (from-to)	126-32
Number of pages	7
Journal	Clinical and Experimental Allergy
Volume	32
Issue number	1
DOIs	https://doi.org/10.1046/j.0022-0477.2001.01252.x
Publication status	Published - Jan 2002

Access to Document

10.1046/j.0022-0477.2001.01252.x

Cite this

@article{de946aaccae9412d9a7a21dff6876e8c,

title = "A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis",

abstract = "The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.",

author = "Wilson, {A. M.} and Orr, {L. C.} and Coutie, {W. J. R.} and Sims, {E. J.} and Lipworth, {B. J.}",

year = "2002",

month = jan,

doi = "10.1046/j.0022-0477.2001.01252.x",

language = "English",

volume = "32",

pages = "126--32",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

AU - Wilson, A. M.

AU - Orr, L. C.

AU - Coutie, W. J. R.

AU - Sims, E. J.

AU - Lipworth, B. J.

PY - 2002/1

Y1 - 2002/1

N2 - The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.

AB - The combination of montelukast (ML) and loratadine (LT) has previously been shown to be superior to either drug alone in managing seasonal allergic rhinitis (SAR), whilst fexofenadine (FEX) has been shown to be better than LT as monotherapy.

U2 - 10.1046/j.0022-0477.2001.01252.x

DO - 10.1046/j.0022-0477.2001.01252.x

M3 - Article

C2 - 12002729

SN - 0954-7894

VL - 32

SP - 126

EP - 132

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 1

ER -

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

Abstract

Access to Document

Fingerprint

Cite this